Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02447783 · ClinicalTrials.gov registry record · NA

Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 2

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT02447783 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 75 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02447783, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

Flavanols are plant-derived compounds commonly present in the human diet. Examples of flavanol-containing foods and beverages are apples, chocolate, tea, wine, berries, pomegranate and nuts. The consumption of flavanol-containing foods and beverages has been associated with improvements in cardiovascular health. In this study, the investigators hope to learn more about the effects of long term consumptions of cocoa flavanols on blood pressure, platelet function and other metabolic parameters in healthy humans. This study is a continuation of a previous study investigating the consumptions of increasing amounts of cocoa flavanols on blood pressure, platelet function and other metabolic parameters in healthy humans

Interventions

  • DIETARY_SUPPLEMENT Mars Cocoa Extract Capsules
  • DIETARY_SUPPLEMENT Control Capsules

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2012-06
Est. Completion 2012-12
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT02447783

The ClinicalTrials.gov registry entry for NCT02447783 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mars Cocoa Extract Capsules is the first listed.

NCT02447783 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02447783 about?

NCT02447783 is a clinical study titled "Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 2". Flavanols are plant-derived compounds commonly present in the human diet. Examples of flavanol-containing foods and beverages are apples, chocolate, tea, wine, berries, pomegranate and nuts. The consumption of flavanol-containing foods and beverages has been associated with improvements in cardiovas...

What is the current status of trial NCT02447783?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2012-06. Estimated completion is 2012-12.

What interventions are being tested in trial NCT02447783?

The interventions under investigation include: Mars Cocoa Extract Capsules (DIETARY_SUPPLEMENT), Control Capsules (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02447783?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.